Suzana Jordan

Effects and safety of rituximab in systemic sclerosis: an analysis from the European Scleroderma Trial and Research (EUSTAR) group

Suzana Jordan, Jörg H. W. Distler, Britta Maurer et al. · Annals of the Rheumatic Diseases · 2014 · 428 citations · Full text

Medicine, Immunology, Pharmacotherapy +13

The European Scleroderma Trials and Research group (EUSTAR) task force for the development of revised activity criteria for systemic sclerosis: derivation and validation of a preliminarily revised EUSTAR activity index

Gabriele Valentini, Michele Iudici, Ulrich A. Walker et al. · Annals of the Rheumatic Diseases · 2016 · 234 citations · Full text

Medicine, Clinical Sciences, Internal Medicine +15

Brief Report: Pulmonary Function Tests: High Rate of False‐Negative Results in the Early Detection and Screening of Scleroderma‐Related Interstitial Lung Disease

Yossra A. Suliman, Rucsandra Dobrota, Dörte Huscher et al. · Arthritis & Rheumatology · 2015 · 223 citations

Medicine, Internal Medicine, Radiology +16

Prediction of progression of interstitial lung disease in patients with systemic sclerosis: the SPAR model

Wanlong Wu, Suzana Jordan, Mike Oliver Becker et al. · Annals of the Rheumatic Diseases · 2018 · 143 citations · Full text

Medicine, Clinical Sciences, Internal Medicine +17

Progressive skin fibrosis is associated with a decline in lung function and worse survival in patients with diffuse cutaneous systemic sclerosis in the European Scleroderma Trials and Research (EUSTAR) cohort

Wanlong Wu, Suzana Jordan, Nicole Graf et al. · Annals of the Rheumatic Diseases · 2019 · 132 citations · Full text

Medicine, Clinical Sciences, Dermatology +13